Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Inhibition of complement‐mediated immune hemolysis by the constant domain of immunoglobulin

Inhibition of complement‐mediated immune hemolysis by the constant domain of immunoglobulin Abstract: It has been reported that high‐dose administration of intravenous immunoglobulin (IVIG) is useful for the inhibition of complement‐dependent immune cytolysis, which is the first event of xenogeneic hyperacute rejection. We have found that monomeric peptide residues 289–292 and 282–292 from the second constant domain of the γ‐chain of the human IgG, part of the Clq binding sites, was also effective in inhibition of pig RBC lysis by human serum, and IgM‐rich IVIG (Pentaglobulin) was more active than IVIG in this assay. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Xenotransplantation Wiley

Inhibition of complement‐mediated immune hemolysis by the constant domain of immunoglobulin

Loading next page...
 
/lp/wiley/inhibition-of-complement-mediated-immune-hemolysis-by-the-constant-gDGUOA6NGa

References (7)

Publisher
Wiley
Copyright
© 1997 Munksgaard
ISSN
0908-665X
eISSN
1399-3089
DOI
10.1111/j.1399-3089.1997.tb00168.x
Publisher site
See Article on Publisher Site

Abstract

Abstract: It has been reported that high‐dose administration of intravenous immunoglobulin (IVIG) is useful for the inhibition of complement‐dependent immune cytolysis, which is the first event of xenogeneic hyperacute rejection. We have found that monomeric peptide residues 289–292 and 282–292 from the second constant domain of the γ‐chain of the human IgG, part of the Clq binding sites, was also effective in inhibition of pig RBC lysis by human serum, and IgM‐rich IVIG (Pentaglobulin) was more active than IVIG in this assay.

Journal

XenotransplantationWiley

Published: May 1, 1997

There are no references for this article.